In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roche's European in vitro device business to be folded into Boehringer Mannheim's under integration plan.

This article was originally published in The Gray Sheet

Executive Summary

ROCHE EUROPEAN DIAGNOSTICS UNITS WOULD BE FOLDED INTO BOEHRINGER FACILITIES under Roche's integration plan for Boehringer Mannheim. The proposal, which would eliminate 4,000-5,000 of the combined companies' 74,000 employees, calls for Boehringer to take over the functions of Roche's Kaiseraugst, Switzerland and Grenzach, Germany in vitro diagnostics operations. Roche announced a definitive agreement to purchase Boehringer Mannheim parent Corange on May 26 ("The Gray Sheet" June 2, p. 3); the deal is expected to close by the end of the year.

You may also be interested in...

Spin-out A Neat Solution For Sanofi’s Manufacturing Millstone

Stada Grabs GSK Brands In Key EU Markets

Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales in excess of €100m.

Brazil Levels Medtech ICT Tariffs Playing Field

All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts